IP Library Granted Patent US 10,568,762
Granted Patent B2
US 10,568,762 · App. 16/392,534 · Granted Feb 25, 2020

Stent for treating ocular disorders

Inventors: Mary G. Lynch (Atlanta, GA); Reay H. Brown (Atlanta, GA)
Assignee: GLAUKOS CORPORATION
A61F9/00781A61M25/007A61F9/0017A61F2230/0008A61F2250/0067A61M25/0074A61M2210/0612
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,568,762
App. No.
16/392,534
Granted
Feb 25, 2020
Kind
B2
Abstract

Shunt devices and a method for continuously decompressing elevated intraocular pressure in eyes affected by glaucoma by diverting excess aqueous humor from the anterior chamber of the eye into Schlemm's canal where post-operative patency can be maintained with an indwelling shunt device which surgically connects the canal with the anterior chamber. The shunt devices provide uni- or bi-directional flow of aqueous humor into Schlemm's canal.

Claims (24)

1. A stent for use in an eye to enhance drainage of aqueous fluid from an anterior chamber of an eye into one or more collecting channels on an outer wall of Schlemm's canal of the eye, wherein the stent comprises:

a biocompatible metal body shaped to reside partially within Schlemm's canal, the body having a trough-like aspect that is oriented to open toward the outer wall of Schlemm's canal when positioned in the eye,

wherein the trough-like aspect extends to a distal end of the body,

wherein the body further comprises an inlet at a proximal end shaped to reside at least partially within the anterior chamber,

wherein the body further comprises a fenestration located between the proximal end and the distal end of the body.

2. The stent of claim 1 , wherein the body comprises a pre-formed curvature.

3. The stent of claim 1 , wherein the body comprises a central longitudinal axis, and wherein the central longitudinal axis is within the trough-like aspect.

4. The stent of claim 1 , wherein the fenestration is oval-shaped.

5. The stent of claim 4 , wherein the body comprises multiple fenestrations located between the proximal end and the distal end of the body.

6. The stent of claim 1 , wherein the body is non-luminal.

7. The stent of claim 1 , wherein the stent is sized and shaped to extend within at least 6 mm of Schlemm's canal.

8. The stent of claim 7 , wherein an inner cross-sectional dimension of the body is between 0.1 mm and 0.5 mm.

9. An implant designed to relieve elevated intraocular pressure, the implant comprising:

a biocompatible metal stent having approximately 6 mm of its length forming a curved length shaped to reside within Schlemm's canal of an eye,

wherein the curved length has a trough-like shape,

the stent being configured such that the trough-like shape is oriented to open toward one or more collecting channels of Schlemm's canal when positioned in the eye,

wherein the curved length further includes a fenestration, and

wherein the stent further includes an inlet at its proximal end shaped to reside at least partially within the anterior chamber.

10. The implant of claim 9 , wherein the stent comprises a central longitudinal axis, and wherein the central longitudinal axis is within the curved length.

11. The implant of claim 9 , wherein the fenestration is oval-shaped.

12. The implant of claim 9 , wherein the stent comprises multiple fenestrations located between the proximal end and a distal end of the stent.

13. The implant of claim 9 , wherein the trough-like shape extends to the distal end of the stent.

14. The implant of claim 9 , wherein a distal end of the curved length is non-tubular.

15. The implant of claim 9 , wherein an inner cross-sectional dimension of the stent is between 0.1 mm and 0.5 mm.

Continuity (10)
Continuation 15821130 · Nov 22, 2017
Continuation 15349885 · Nov 11, 2016
Continuation 14316605 · Jun 26, 2014
Continuation 12966889 · Dec 13, 2010
Division 10987114 · Nov 12, 2004
Continuation 10445740 · May 27, 2003
Continuation 10242385 · Sep 12, 2002
Continuation 09558505 · Apr 26, 2000
Provisional Application 60131030 · Apr 26, 1999
Related Publication 20190247232A1 · Aug 15, 2019
Cited By (19)
US 1,137,672 US 12,186,237 US 12,201,555 US 12,201,557 US 12,208,034 US 12,226,308 US 12,279,822 US 12,343,288 US 12,376,989 US 12,414,798 US 12,419,783 US 12,427,057 US 12,478,503 US 12,478,504 US 12,514,750 US 12,575,972 US 12,599,497 US 12,667,486 US 12,702,294